Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Preferred Shares Issued (2022 - 2024)

Historic Preferred Shares Issued for vTv Therapeutics (VTVT) over the last 2 years, with Q4 2024 value amounting to -$50.3 million.

  • vTv Therapeutics' Preferred Shares Issued changed N/A to -$50.3 million in Q4 2024 from the same period last year, while for Sep 2025 it was -$50.3 million, marking a year-over-year decrease of 20000.0%. This contributed to the annual value of $9.7 million for FY2022, which is N/A changed from last year.
  • Per vTv Therapeutics' latest filing, its Preferred Shares Issued stood at -$50.3 million for Q4 2024.
  • vTv Therapeutics' 5-year Preferred Shares Issued high stood at $50.3 million for Q1 2024, and its period low was -$50.3 million during Q4 2024.